Cardelli, L.S.; Cherbi, M.; Huet, F.; Schurtz, G.; Bonnefoy-Cudraz, E.; Gerbaud, E.; Bonello, L.; Leurent, G.; Puymirat, E.; Casella, G.;
et al. Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry. Pharmaceuticals 2023, 16, 1740.
https://doi.org/10.3390/ph16121740
AMA Style
Cardelli LS, Cherbi M, Huet F, Schurtz G, Bonnefoy-Cudraz E, Gerbaud E, Bonello L, Leurent G, Puymirat E, Casella G,
et al. Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry. Pharmaceuticals. 2023; 16(12):1740.
https://doi.org/10.3390/ph16121740
Chicago/Turabian Style
Cardelli, Laura Sofia, Miloud Cherbi, Fabien Huet, Guillaume Schurtz, Eric Bonnefoy-Cudraz, Edouard Gerbaud, Laurent Bonello, Guillaume Leurent, Etienne Puymirat, Gianni Casella,
and et al. 2023. "Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry" Pharmaceuticals 16, no. 12: 1740.
https://doi.org/10.3390/ph16121740
APA Style
Cardelli, L. S., Cherbi, M., Huet, F., Schurtz, G., Bonnefoy-Cudraz, E., Gerbaud, E., Bonello, L., Leurent, G., Puymirat, E., Casella, G., Delmas, C., & Roubille, F.
(2023). Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry. Pharmaceuticals, 16(12), 1740.
https://doi.org/10.3390/ph16121740
